Audience

Read by all 50 of the biggest Pharma companies, like Pfizer and Novartis, as well as thousands of innovative, clinical-stage biotechs.

OUR PLATFORMS draw

252k+
daily email subscribers
700K+
unique monthly visitors
1.8M
average monthly page views
70K+
event registrations

OUR SUBSCRIBERS count

OUR SUBSCRIBERS span

OUR TOP STORIES include

Exclusive: In major test for longevity field, FDA greenlights study on a 'near total reset' of cells
January 27, 2026
US to stop recommending six vaccines for all kids, prioritizing individual choice and higher-risk groups
January 5, 2026
Exclusive: Genentech CEO says switch from one of the largest PBMs will save the company millions
January 11, 2026
Exclusive: Secretive startup Mirador raises $250M, plans to become immunology powerhouse
January 11, 2026
BioMarin vets spearhead new biotech with $82M for rare disease drugs
January 22, 2026

Get started

Connect with us to request a media kit and learn more about rates and availability.

Julie O'Meara
Julie O'Meara
Executive Director, Brand Partnerships, Endpoints News
Melissa Nazzaro